Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-04-09 @ 2:04 AM
Study NCT ID:
NCT00352066
Status:
COMPLETED
Last Update Posted:
2011-06-23
First Post:
2006-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together
Sponsor:
Avexa
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AVX-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Susan Cox
Old Organization:
Avexa